These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15221283)

  • 1. Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation.
    Tomonari A; Iseki T; Takahashi S; Ooi J; Yamada T; Takasugi K; Nagamura F; Uchimaru K; Tojo A; Asano S
    Ann Hematol; 2004 Sep; 83(9):573-7. PubMed ID: 15221283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Takasugi K; Iseki T; Tojo A; Asano S
    Bone Marrow Transplant; 2008 Feb; 41(4):371-6. PubMed ID: 17982495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection.
    Roberts WD; Weinberg KI; Kohn DB; Sender L; Parkman R; Lenarsky C
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):320-3. PubMed ID: 8392303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.
    Vij R; Khoury H; Brown R; Goodnough LT; Devine SM; Blum W; Adkins D; DiPersio JF
    Bone Marrow Transplant; 2003 Oct; 32(7):703-7. PubMed ID: 13130318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of myelotoxicity in a case of bone marrow transplantation using granulocyte-macrophage colony-stimulating factor along with ganciclovir].
    Reynoso Gómez E; Dueñas González A; Miranda López E; Sobrevilla Calvo P; Donis Hernández J; Texcocano Becerra J; Salinas Rojas V
    Rev Invest Clin; 1996; 48(1):55-8. PubMed ID: 8815488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT.
    Klumpp TR; Herman JH; Schnell MK; Goldberg SL; Mangan KF
    Bone Marrow Transplant; 1996 Sep; 18(3):559-64. PubMed ID: 8879617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients.
    Venton G; Crocchiolo R; Fürst S; Granata A; Oudin C; Faucher C; Coso D; Bouabdallah R; Berger P; Vey N; Ladaique P; Chabannon C; le Merlin M; Blaise D; El-Cheikh J
    Clin Microbiol Infect; 2014 Feb; 20(2):160-6. PubMed ID: 23607363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients.
    Matsumura T; Narimatsu H; Kami M; Yuji K; Kusumi E; Hori A; Murashige N; Tanaka Y; Masuoka K; Wake A; Miyakoshi S; Kanda Y; Taniguchi S
    Biol Blood Marrow Transplant; 2007 May; 13(5):577-83. PubMed ID: 17448917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation.
    Goodrich JM; Mori M; Gleaves CA; Du Mond C; Cays M; Ebeling DF; Buhles WC; DeArmond B; Meyers JD
    N Engl J Med; 1991 Dec; 325(23):1601-7. PubMed ID: 1658652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Yamaguchi T; Tojo A; Asano S
    Eur J Haematol; 2008 Mar; 80(3):251-7. PubMed ID: 18081702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
    Narimatsu H; Kami M; Kato D; Matsumura T; Murashige N; Kusumi E; Yuji K; Hori A; Shibata T; Masuoka K; Wake A; Miyakoshi S; Morinaga S; Taniguchi S
    Transpl Infect Dis; 2007 Mar; 9(1):11-5. PubMed ID: 17313465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan.
    Tomonari A; Iseki T; Ooi J; Takahashi S; Shindo M; Ishii K; Nagamura F; Uchimaru K; Tani K; Tojo A; Asano S
    Br J Haematol; 2003 Apr; 121(2):304-11. PubMed ID: 12694253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome.
    Salzberger B; Bowden RA; Hackman RC; Davis C; Boeckh M
    Blood; 1997 Sep; 90(6):2502-8. PubMed ID: 9310503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of foscarnet for preemptive therapy against cytomegalovirus reactivation after unrelated cord blood transplantation.
    Takami A; Mochizuki K; Ito S; Sugimori C; Yamashita T; Asakura H; Okumura H; Nakao S
    Transplant Proc; 2007; 39(1):237-9. PubMed ID: 17275512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases.
    Maeda T; Shiozawa E; Mayumi H; Usui T; Nakashima H; Hattori N; Adachi D; Saito B; Yanagisawa K; Matsuda I; Nakamaki T; Tomoyasu S; Yamochi-Onizuka T; Takimoto M; Ota H
    Pathol Int; 2008 Feb; 58(2):126-32. PubMed ID: 18199163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy.
    Akpek G; Knight RD; Wright DG
    Am J Hematol; 2003 Jan; 72(1):13-9. PubMed ID: 12508262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
    Valentine VG; Weill D; Gupta MR; Raper B; Laplace SG; Lombard GA; Bonvillain RW; Taylor DE; Dhillon GS
    J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.